Natera, Inc. (NTRA)
NASDAQ: NTRA · IEX Real-Time Price · USD
110.70
+2.89 (2.68%)
At close: Jul 2, 2024, 4:00 PM
107.50
-3.20 (-2.89%)
After-hours: Jul 2, 2024, 7:25 PM EDT
Natera Employees
Natera had 3,293 employees as of December 31, 2023. The number of employees increased by 275 or 9.11% compared to the previous year.
Employees
3,293
Change (1Y)
275
Growth (1Y)
9.11%
Revenue / Employee
$367,008
Profits / Employee
-$110,982
Market Cap
13.59B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3,293 | 275 | 9.11% |
Dec 31, 2022 | 3,018 | 348 | 13.03% |
Dec 31, 2021 | 2,670 | 855 | 47.11% |
Dec 31, 2020 | 1,815 | 776 | 74.69% |
Dec 31, 2019 | 1,039 | 64 | 6.56% |
Dec 31, 2018 | 975 | 82 | 9.18% |
Dec 31, 2017 | 893 | 41 | 4.81% |
Dec 31, 2016 | 852 | 136 | 18.99% |
Dec 31, 2015 | 716 | 42 | 6.23% |
Dec 31, 2014 | 674 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Tenet Healthcare | 106,500 |
Viatris | 38,000 |
Dr. Reddy's Laboratories | 25,863 |
Revvity | 11,500 |
Medpace Holdings | 5,900 |
Insulet | 3,000 |
Incyte | 2,524 |
Neurocrine Biosciences | 1,400 |
NTRA News
- 5 days ago - Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer - Business Wire
- 15 days ago - Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients - Business Wire
- 4 weeks ago - Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - Business Wire
- 4 weeks ago - Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024 - Business Wire
- 5 weeks ago - Natera to Present at the 2024 Leerink Partners Healthcare Crossroads Conference - Business Wire
- 5 weeks ago - Natera Announces New MRD Data in Multiple Tumor Types, to be Presented at ASCO Annual Meeting - Business Wire
- 7 weeks ago - Natera Reports First Quarter 2024 Financial Results - Business Wire
- 2 months ago - New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer - Business Wire